Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment.
about
Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Population pharmacokinetic ana ...... d moderate hepatic impairment.
@en
Population pharmacokinetic ana ...... d moderate hepatic impairment.
@nl
type
label
Population pharmacokinetic ana ...... d moderate hepatic impairment.
@en
Population pharmacokinetic ana ...... d moderate hepatic impairment.
@nl
prefLabel
Population pharmacokinetic ana ...... d moderate hepatic impairment.
@en
Population pharmacokinetic ana ...... d moderate hepatic impairment.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetic ana ...... d moderate hepatic impairment.
@en
P2093
Donghoon Shin
In-Jin Jang
Jongtae Lee
Mi Young Bahng
Yong Jin Jung
P2860
P304
P356
10.1111/BCP.12977
P407
P577
2016-04-16T00:00:00Z